MARA Holdings, Inc. annual report, FY2013

Full document

SEC filing summary

Filing and period: This is Marathon Patent Group, Inc.’s Form 10-K for the fiscal year ended December 31, 2013, filed March 31, 2014—not a quarterly report. The supplied company metadata says “MARA Holdings, Inc.” and “2013 Q4”; those labels do not match the filing’s registrant and annual reporting period.

Business context

The company acquired patents and sought to monetize them through licensing, settlements, and infringement enforcement. It discontinued its earlier mining and real-estate businesses. At year-end, it reported 118 U.S. and foreign patents and five applications, with 57 active defendants in patent cases. Operations changed substantially during 2013, so comparison with 2012 is affected by the business transition.

Financial results and liquidity

  • Revenue: $3.42 million in 2013, versus none in 2012. The filing identifies $1.72 million as cash-based revenue and $1.70 million as noncash revenue from patents received in settlements.
  • Costs and losses: Direct costs of revenue were $957,040; patent amortization was $1.04 million; total operating expenses were $7.09 million. Operating loss was $3.68 million, compared with $5.54 million in 2012. Net loss attributable to Marathon was $3.45 million, versus $6.93 million; basic and diluted loss per share was $0.75, versus $2.49.
  • Margins: The filing does not report a gross margin percentage. Patent amortization and other operating costs substantially exceeded revenue.
  • Cash flow: Operating activities used $1.52 million; investing activities used $3.00 million, including patent and CyberFone acquisitions; financing activities provided $5.78 million.
  • Liquidity: Year-end cash was $3.61 million, up from $2.35 million; working capital was $3.85 million. Management said cash was sufficient to fund current operations at least through March 2015, while warning additional funding could be needed sooner.
  • Debt and balance sheet: Total liabilities were $785,609, principally accounts payable and accrued expenses; the $500,000 CyberFone acquisition note was repaid in June 2013. Total assets were $12.96 million, including $6.16 million of net intangible assets and $2.14 million of goodwill.
  • Capital and dilution: The company raised $5.78 million net through equity financing. Year-end shares outstanding were 5,489,593; outstanding warrants and options could add dilution. No cash dividends were paid or expected in the foreseeable future.

Material changes, outlook, and risks

  • Revenue began in 2013, but two customers represented approximately 55% of annual revenue, and two customers accounted for all year-end net receivables. Patent settlements also contributed $1.70 million of noncash revenue.
  • The company acquired multiple portfolios, including CyberFone, and reported year-end patent intangibles of $6.16 million. Acquisition values, patent recoverability, and future monetization depend on management estimates and uncertain enforcement outcomes.
  • Management described revenue timing as unpredictable and the monetization cycle as lengthy and costly. Litigation can require substantial legal spending and may end in adverse validity, infringement, or procedural rulings; patent-law changes could add uncertainty and expense.
  • At December 31, the company reported disclosure controls and internal controls over financial reporting as ineffective. Management cited limited internal-audit resources and inadequate segregation of accounting duties, with a risk that material misstatements might not be prevented or detected timely.
  • The independent auditor issued an unqualified opinion on the financial statements and did not express an opinion on internal-control effectiveness. The filing says the prior going-concern uncertainty was no longer included in the 2013 audit opinion.
  • Related-party and governance items warrant attention: CEO Doug Croxall was affiliated with the seller of the initial Sampo portfolio; director Craig Nard was a principal of a consultant receiving options; and the CEO received a $350,000 bonus and options in 2013. The company also disclosed a seven-year Los Angeles office lease and a post-year-end March 2014 licensing agreement with RPX, with financial terms not provided in this text.

Most important facts for investors to verify

  1. Confirm the registrant and period: the filing is Marathon Patent Group, Inc.’s 2013 annual report, not a MARA Holdings quarterly filing.
  2. Reconcile reported revenue to cash collections, the $1.70 million of patent consideration, customer concentration, and the collectability of year-end receivables.
  3. Review the status, costs, and outcomes of the 57-defendant litigation matters, including any challenges to patent validity or enforceability.
  4. Assess cash burn, acquisition spending, patent and goodwill impairment assumptions, and the evidence supporting management’s March 2015 liquidity estimate.
  5. Check remediation of the disclosed ineffective controls, equity-linked dilution, related-party arrangements, and the terms and subsequent results of the RPX agreements.